Search

Board Moves February 16, 2017

Medibio has appointed US-based Jack Cosentino as chief executive and managing director. Kris Knauer, former chief executive, will become interim chief financial officer until a permanent appointment has been made.  After which Mr  Knauer will remain on the board as non-executive director.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Medibio (MEB)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
37thiCollege275%5%
148thSterling Plantations88%-24%
239thFamily Zone Cyber Safety44%0%
389thKatana Capital11%5%
773rdMedibio-63%6%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

18/06/18
$0 Issued
18/06/18
$0 Issued
18/06/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

110th↑Medibio$3.1m
121st↓Katana Capital$2.4m
122nd↓Sterling Plantations$2.3m
124th↑Family Zone Cyber Safety$2.3m
125th↓iCollege$2.0m
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Medibio

842ndFrank Prendergast$119k
536thChris Indermaur$50k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer